Free tool
FAERS Monitor: Hemabate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017989 or its brand name (Hemabate, Carboprost Tromethamine). Reports on generic versions are filed under their own applications.
Reports
734
Serious
702
96% of reports
Hospitalization
77
Death reported
2
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- vomiting224
- nausea199
- diarrhoea144
- off label use144
- abdominal pain upper102
- chest discomfort95
- abdominal pain71
- abdominal discomfort69
- dyspnoea67
- blood pressure increased63
- hyperhidrosis41
- palpitations41
- gastrointestinal disorder40
- headache38
- dizziness37
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 5 |
| 2013 | 7 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 9 |
| 2017 | 7 |
| 2018 | 12 |
| 2019 | 19 |
| 2020 | 33 |
| 2021 | 90 |
| 2022 | 138 |
| 2023 | 131 |
| 2024 | 121 |
| 2025 | 83 |
| 2026 | 52 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,425 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| chest discomfortSignal | 95 | 26.6 | 22.1 | 2,325 |
| abdominal pain upperSignal | 102 | 14.2 | 11.9 | 1,250 |
| vomitingSignal | 224 | 13.7 | 12.2 | 2,674 |
| gastrointestinal disorderSignal | 40 | 12.8 | 9.5 | 425 |
| blood pressure increasedSignal | 63 | 11.8 | 9.3 | 617 |
| abdominal discomfortSignal | 69 | 11.8 | 9.4 | 676 |
| palpitationsSignal | 41 | 10.0 | 7.5 | 326 |
| hyperhidrosisSignal | 41 | 9.1 | 6.8 | 290 |
| abdominal painSignal | 71 | 8.7 | 7.0 | 485 |
| nauseaSignal | 199 | 7.2 | 6.4 | 1,099 |
| diarrhoeaSignal | 144 | 6.4 | 5.5 | 670 |
| off label useSignal | 144 | 4.7 | 4.1 | 436 |
| dyspnoeaSignal | 67 | 3.4 | 2.7 | 114 |
| dizzinessSignal | 37 | 2.1 | 1.6 | 21 |
| headache | 38 | 1.7 | 1.3 | 11 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.